Reduction in cardiovascular death after kidney transplantation

Transplantation

Volumn 89, Issue 7, 2010, Pages 851-857

  Pilmore, Helen ^a   Dent, Hannah ^b   Chang, Sean ^b   McDonald, Stephen P ^b   Chadban, Steven J ^b,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Queen Elizabeth II Hospital   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cardiovascular; Glomerular filtration rate; Kidney; Mortality; Transplantation

Indexed keywords

ADULT; AGED; AGING; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PRIORITY JOURNAL; RISK MANAGEMENT; RISK REDUCTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUSTRALIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW ZEALAND; ODDS RATIO; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950944041     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181caeead     Document Type: Article

References (26)

1. McDonald S, Excell L, Livingston B. ANZDATA Registry Report 2008. Adelaide, South Australia, Australia and New Zealand Dialysis and Transplant Registry 2008.
2. Brunkhorst R, Lufft V, Dannenberg B, et al. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: A case-control study. Transplantation 2003; 76: 115.
3. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388.
4. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289.
5. Matas AJ, Humar A, Gillingham KJ, et al. Five preventable causes of kidney graft loss in the 1990s: A single-center analysis. Kidney Int 2002; 62: 704.
6. McDonald SP, Excell L, Livingston B. ANZDATA Registry Report 2008. Adelaide, Australia and New Zealand Dialysis and Transplant Registry, 2008. Available at: http://www.anzdata.org.au/v1/report- 2008.
7. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524.
8. Australian Bureau of Statistics 2006; Causes of Death 3303.3. Available at: http://www.abs.gov.au. Accessed December 28, 2009.
9. Chang SH, Russ GR, Chadban SJ, et al. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 2007; 84: 611.
10. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
11. McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002; 17: 2212.
12. Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006; 17: 900.
13. Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008; 85: 209.
14. de Mattos AM, Prather J,Olyaei AJ, et al. Cardiovascular events following renal transplantation: Role of traditional and transplant-specific risk factors. Kidney Int 2006; 70: 757.
15. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291.
16. Baid-Agrawal S, Delmonico FL, Tolkoff-Rubin NE, et al. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation 2004; 77: 1199.
17. Morrisett JD, Abdel-Fattah G, Hoogeveen R, et al. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res 2002; 43: 1170.
18. Perrea DN, Moulakakis KG, Poulakou MV, et al. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function. Int Urol Nephrol 2008; 40: 521.
19. Vincenti F, Friman S, Scheuermann E, et al.; DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Ta-crolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclospor-ine versus tacrolimus. Am J Transplant 2007; 7: 1506.
20. Snyder JJ, Kasiske BL, Gilbertson DT, et al. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002; 62: 1423.
21. Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, et al. The role of pretransplantation renal replacement therapy modality in kidney allo-graft and recipient survival. Am J Kidney Dis 2005; 46: 537.
22. McDonald SP, Marshall MR, Johnson DW, et al. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20: 155.
23. Johnson DW, Armstrong K,Campbell SB,et al. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007; 12: 391.
24. Winkelmayer WC, Levin R, Setoguchi S. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol 2008; 3: 1415.
25. Norris K, Bourgoigne J, Gassman J, et al.; AASK Study Group. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 2006; 48: 739.
26. Jardine AG, Holdaas H, Fellström B, et al.; ALERT Study Investigators. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT Study. Am J Transplant 2004; 4: 988.